Skip to content

EV / sales at other companies

National Healthcare logo
National HealthcareNHC
1.6×+0.5×
The Ensign Group logo
The Ensign GroupENSG
2.5×+0.5×
PACS Group logo
PACS GroupPACS
1.5×+0.4×
Sabra Healthcare logo
Sabra HealthcareSBRA
5.8×+0.1×
Welltower logo
WelltowerWELL
11.5×+0.1×
American Healthcare REIT logo
American Healthcare REITAHR
4.5×+1.4×

Other financials

Income statement

See full
Revenue$764.9M-6.0%
Operating income$51.8M+75.1%
Net income-$6.9M+89.4%
EPS (diluted)-$0.03+89.3%

Balance sheet

See full
Cash & equivalents$333.7M+5.5%
Total debt$5.5B-1.5%
Total equity-$55.9M-138%
Total assets$5.9B-5.0%

Cash flow

See full
Operating cash flow$20.9M-10.7%
CapEx$46.5M+11.1%
Free cash flow-$25.6M-39.0%

Valuation

See full
Market cap$3.31B+160%

Profitability

See full
Operating margin1.1%-0.7pp
Net margin-6.5%-0.8pp
FCF margin1.3%

Returns & leverage

See full
Return on equity-108.9%-464pp
Debt / equity52.7×+38.9×
Current ratio+0.2×

Where this comes from

Calculated from Brookdale Senior Living’s reported figures.

Based on the most recent quarter.

The official record: Brookdale Senior Living’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Brookdale Senior Living's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Brookdale Senior Living's EV / sales?
Brookdale Senior Living (BKD) reported EV / sales of 2.7× in Q1 2026.
How has Brookdale Senior Living's EV / sales changed year-over-year?
Brookdale Senior Living's EV / sales increased by 29.6% year-over-year, from 2.1× to 2.7×.
What is the long-term trend for Brookdale Senior Living's EV / sales?
Over 5 years (2020 to 2025), Brookdale Senior Living's EV / sales has grown at a 8.1% compound annual growth rate (CAGR), from 1.6× to 2.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.